search
Back to results

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Primary Purpose

Metastatic Breast Cancer, Advanced Breast Cancer, Metastatic Castration Resistant Prostate Cancer

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
sunitinib
Sponsored by
Pfizer
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Metastatic Breast Cancer focused on measuring Potentially other tumor types in the future

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Must have ended treatment from one of the following sunitinib studies: A6181030, A6181064, A6181078, A6181087, A6181094, A6181107, A6181108, A6181110, A6181111, A6181112, A6181113, A6181120, A6181126 and A6181170. Other Pfizer sponsored sunitinib studies may be included in the future.

Exclusion Criteria:

  • See inclusion criteria

Sites / Locations

  • Emory University, Winship Cancer Institute
  • Investigational Drug Service
  • The Emory Clinic
  • Loyola University Medical Center
  • University of Iowa Hospitals and Clinics
  • Siteman Cancer Center-West County
  • Barnes Jewish Hospital
  • Washington University School of Medicine, Siteman Cancer Center
  • Siteman Cancer Center
  • Comprehensive Cancer Center of Nevada
  • Comprehensive Cancer Centers of Nevada
  • Northwest Cancer Specialists, P.C.
  • Northwest Cancer Specialists, P.C.
  • US Oncology Research and Clinical Pharmacy (Drug Shipment Only)
  • The Strelitz Diabetes Institute of Eastern Virginia Medical School
  • Clinica Viedma
  • Centro Oncológico Rosario
  • Instituto Oncologico de Cordoba
  • Centro Medico San Roque
  • Royal Brisbane & Women's Hospital
  • Royal Adelaide Hospital, Department of Medical Oncology
  • Austin Health
  • Royal Melbourne Hospital
  • Mount Medical Centre
  • Hopital Erasme / Gastroenterologie
  • Cliniques Universitaires Saint Luc / Gastroentérologie
  • Cliniques Universitaires Saint-Luc, Oncologie
  • UZ Gasthuisberg, Department Internal Medicine - Gastroenterology - Gastro-intestinal Oncology
  • Centre Hospitalier Universitaire de Liege
  • Algemeen Ziekenhuis Nikolaas
  • AZ Sint-Augustinus, Oncologisch Centrum
  • Hospital São Lucas da PUCRS
  • Hospital Nossa Senhora da Conceicao
  • Sociedade Beneficente de Senhoras Hospital Sirio Libanes
  • Centro de Oncologia do Instituto de Radiologia
  • BC Cancer Agency - Vancouver Centre
  • QEII Health Sciences Centre - Nova Scotia Cancer Centre
  • QEII Health Sciences Centre - Victoria General Site
  • QEII Health Sciences Centre - Halifax Infirmary Site
  • London Regional Cancer Program
  • Princess Margaret Hospital
  • CHUM, Hopital Saint-Luc
  • Royal Victoria Hospital
  • Fundacion Centro de Investigacion Clinica CIC
  • Hospital Universitario San Vicente de Paul
  • Clinica Astorga
  • Centre Antoine Lacassagne
  • Hopital Beaujon
  • Groupe Hospitalier Cochin, Cancer Quest AP-HP
  • CHU-Hôpital Jean Minjoz
  • Hopital Saint-Andre
  • Centre Jean Perrin
  • Polyclinique du Bois
  • Centre Oscar Lambret
  • Hopital Edouard Herriot
  • Centre Leon Berard
  • Chu La Timone
  • Clinique Hartmann
  • Hopital Saint-Antoine
  • Centre Eugene Marquis
  • Klinik fuer Innere Medizin, Gastroenterologie, Onkologie, Endokrinologie
  • Universitaetsklinikum Charité, Campus Virchow Klinikum
  • eps - early phase GmbH
  • Frauenaerzte Pruener Gang
  • Klinik fuer Frauenheilkunde und Geburtshilfe, Universitaetsklinikum Schleswig-Holstein
  • Universitaetsklinikum Schleswig-Holstein, Campus Luebeck
  • Universitaetsklinikum Giessen und Marburg, Standort Marburg
  • Rhoen Klinikum Meiningen, Gynaekologie und Geburtshilfe
  • Frauenklinik und Poliklinik, Klinikum rechts der Isar, Technische Universitaet Muenchen
  • Department of Clinical Oncology, Tuen Mun Hospital
  • Queen Mary Hospital
  • Division of Haematology/Oncology, Department of Medicine, Queen Mary Hospital,
  • Queen Elizabeth Hospital, Department of Clinical Oncology
  • Tuen Mun Hospital, Department of Clinical Oncology
  • UNIMED Medical Institute
  • National Cancer Center
  • Seoul National University Bundang Hospital
  • Seoul National University Hospital / Department of Internal Medecine
  • Asan Medical Center, Division of Oncology, Department of Internal Medicine
  • Yeungnam University Medical Center/Department of Internal medicine
  • Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine
  • Hospital Universitario Dr. Jose Eleuterio Gonzalez Centro Universitario contra el cancer
  • Hospital Christus Muguerza del Parque
  • Cancer Care Clinic
  • National University Hospital/Department of Heamatology-Oncology
  • National Cancer Center/Department of Medical Oncology
  • Corporacio Sanitaria Parc Tauli
  • Fundacion Hospital Alcorcon
  • Servicio de Oncologia
  • Complexo Hospitalario Universitario A Coruña
  • Centro Oncologico Md Anderson International España
  • Hospital Clinico San Carlos
  • Hospital 12 de Octubre
  • Hospital Universitario La Paz
  • Chang Gung Medical Foundation, Linkou Branch
  • Changhua Christian Hospital
  • Chung-Ho Memorial Hospital, Kaohsiung Medical University/Department of Surgery
  • Chi Mei Medical Center, Liouying
  • Taichung Veterans General Hospital, Department of Surgery
  • National Taiwan University Hospital/Department of Oncology
  • Koo Foundation Sun Yat-Sen Cancer Center, Div. of Hematology/Oncology
  • Taipei Veterans General Hospital
  • Chi-Mei Medical Center
  • Division of Surgery and Oncology
  • Deparment of Cardiology
  • The Beatson West of Scotland Cancer Centre
  • Dainton Building
  • St James' Institute of Oncology
  • Management Offices, 4th Floor, Thomas Guy House
  • Royal Marsden Hospital
  • Department of Medical Oncology
  • Cardiology Department, Wythenshawe Hospital
  • Nottingham City Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

A

Arm Description

Sunitinib will be administered in a continuous daily dose (oral, once per day). Starting dose will be 37.5 mg daily unless the patient was on a different dose (25 mg or 50 mg daily) on the previous trial. In that case, they will begin treatment on this study at the same dose used at the end of the previous study. The protocol now allows for patients on dosing regimens other than only continuous dosing (e.g. 4/2, etc.) to be enrolled if eligible.

Outcomes

Primary Outcome Measures

Number of Participants With Treatment-emergent Adverse Events (AEs) (All Causalities)
Assessment of AEs included type, incidence, severity (graded by the National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE], Version 3.0, timing, seriousness, and relatedness; and laboratory abnormalities.
Number of Participants With Treatment-emergent AEs (Treatment-Related)
Assessment of AEs included type, incidence, severity (graded by the National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE], Version 3.0, timing, seriousness, and relatedness; and laboratory abnormalities.

Secondary Outcome Measures

Full Information

First Posted
January 26, 2007
Last Updated
June 20, 2019
Sponsor
Pfizer
search

1. Study Identification

Unique Protocol Identification Number
NCT00428220
Brief Title
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Official Title
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
July 2007 (undefined)
Primary Completion Date
August 2014 (Actual)
Study Completion Date
September 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Pfizer

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a study using sunitinib for patients ending treatment on a previous sunitinib malate protocol to continue to receive sunitinib. The patient must have been enrolled in one of the following studies: A6181030, A6181064, A6181078, A6181087, A6181094, A6181107, A6181108, A6181110, A6181111, A6181112, A6181113, A6181120, A6181126 and A6181170. Other Pfizer sponsored sunitinib studies may be included in the future.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metastatic Breast Cancer, Advanced Breast Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Renal Cell Cancer, Non-Small Cell Lung Cancer, Thyroid Cancer, Advanced/Metastatic Non-Small Cell Lung Cancer, Advanced Gastric Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Pancreatic Islet Cell Carcinoma, Pancreatic Neuroendocrine Tumor
Keywords
Potentially other tumor types in the future

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
223 (Actual)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Experimental
Arm Description
Sunitinib will be administered in a continuous daily dose (oral, once per day). Starting dose will be 37.5 mg daily unless the patient was on a different dose (25 mg or 50 mg daily) on the previous trial. In that case, they will begin treatment on this study at the same dose used at the end of the previous study. The protocol now allows for patients on dosing regimens other than only continuous dosing (e.g. 4/2, etc.) to be enrolled if eligible.
Intervention Type
Drug
Intervention Name(s)
sunitinib
Intervention Description
sunitinib
Primary Outcome Measure Information:
Title
Number of Participants With Treatment-emergent Adverse Events (AEs) (All Causalities)
Description
Assessment of AEs included type, incidence, severity (graded by the National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE], Version 3.0, timing, seriousness, and relatedness; and laboratory abnormalities.
Time Frame
From first day of treatment on the current study up to 28 days post the last dose of study treatment
Title
Number of Participants With Treatment-emergent AEs (Treatment-Related)
Description
Assessment of AEs included type, incidence, severity (graded by the National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE], Version 3.0, timing, seriousness, and relatedness; and laboratory abnormalities.
Time Frame
From first day of treatment on the current study up to 28 days post the last dose of study treatment
Other Pre-specified Outcome Measures:
Title
Summary of Duration of Clinical Benefit
Description
Duration of clinical benefit is defined as the length of time participants remain on sunitinib from the first day of treatment on the parent protocol until the end of sunitinib treatment in this study (A6181114). For participants who were on placebo or a comparator drug in the parent study, duration of clinical benefit is defined as the length of time participants are on sunitinib in this study.
Time Frame
From the first day of treatment in parent study until last day of treatment in A6181114 study.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Must have ended treatment from one of the following sunitinib studies: A6181030, A6181064, A6181078, A6181087, A6181094, A6181107, A6181108, A6181110, A6181111, A6181112, A6181113, A6181120, A6181126 and A6181170. Other Pfizer sponsored sunitinib studies may be included in the future. Exclusion Criteria: See inclusion criteria
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pfizer CT.gov Call Center
Organizational Affiliation
Pfizer
Official's Role
Study Director
Facility Information:
Facility Name
Emory University, Winship Cancer Institute
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
Facility Name
Investigational Drug Service
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
Facility Name
The Emory Clinic
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
Facility Name
Loyola University Medical Center
City
Maywood
State/Province
Illinois
ZIP/Postal Code
60153
Country
United States
Facility Name
University of Iowa Hospitals and Clinics
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Facility Name
Siteman Cancer Center-West County
City
Creve Coeur
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Facility Name
Barnes Jewish Hospital
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Facility Name
Washington University School of Medicine, Siteman Cancer Center
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Facility Name
Siteman Cancer Center
City
Saint Peters
State/Province
Missouri
ZIP/Postal Code
63376
Country
United States
Facility Name
Comprehensive Cancer Center of Nevada
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89128
Country
United States
Facility Name
Comprehensive Cancer Centers of Nevada
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89169
Country
United States
Facility Name
Northwest Cancer Specialists, P.C.
City
Portland
State/Province
Oregon
ZIP/Postal Code
97213-2982
Country
United States
Facility Name
Northwest Cancer Specialists, P.C.
City
Portland
State/Province
Oregon
ZIP/Postal Code
97225
Country
United States
Facility Name
US Oncology Research and Clinical Pharmacy (Drug Shipment Only)
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76177
Country
United States
Facility Name
The Strelitz Diabetes Institute of Eastern Virginia Medical School
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23510
Country
United States
Facility Name
Clinica Viedma
City
Viedma
State/Province
Rio Negro
ZIP/Postal Code
8500
Country
Argentina
Facility Name
Centro Oncológico Rosario
City
Rosario
State/Province
Santa Fé
ZIP/Postal Code
S2000KZE
Country
Argentina
Facility Name
Instituto Oncologico de Cordoba
City
Nueva Cordoba
ZIP/Postal Code
X5006HBF
Country
Argentina
Facility Name
Centro Medico San Roque
City
San Miguel de Tucuman
ZIP/Postal Code
T4000IAK
Country
Argentina
Facility Name
Royal Brisbane & Women's Hospital
City
Herston
State/Province
Queensland
ZIP/Postal Code
4029
Country
Australia
Facility Name
Royal Adelaide Hospital, Department of Medical Oncology
City
Adelaide
State/Province
South Australia
ZIP/Postal Code
5000
Country
Australia
Facility Name
Austin Health
City
Heidelberg
State/Province
Victoria
ZIP/Postal Code
3084
Country
Australia
Facility Name
Royal Melbourne Hospital
City
Parkville
State/Province
Victoria
ZIP/Postal Code
3050
Country
Australia
Facility Name
Mount Medical Centre
City
Perth
State/Province
Western Australia
ZIP/Postal Code
6000
Country
Australia
Facility Name
Hopital Erasme / Gastroenterologie
City
Bruxelles
ZIP/Postal Code
1070
Country
Belgium
Facility Name
Cliniques Universitaires Saint Luc / Gastroentérologie
City
Bruxelles
ZIP/Postal Code
1200
Country
Belgium
Facility Name
Cliniques Universitaires Saint-Luc, Oncologie
City
Bruxelles
ZIP/Postal Code
1200
Country
Belgium
Facility Name
UZ Gasthuisberg, Department Internal Medicine - Gastroenterology - Gastro-intestinal Oncology
City
Leuven
ZIP/Postal Code
B-3000
Country
Belgium
Facility Name
Centre Hospitalier Universitaire de Liege
City
Liege
ZIP/Postal Code
4000
Country
Belgium
Facility Name
Algemeen Ziekenhuis Nikolaas
City
Sint-Niklaas
ZIP/Postal Code
9100
Country
Belgium
Facility Name
AZ Sint-Augustinus, Oncologisch Centrum
City
Wilrijk
ZIP/Postal Code
2610
Country
Belgium
Facility Name
Hospital São Lucas da PUCRS
City
Porto Alegre
State/Province
RS
ZIP/Postal Code
90610-000
Country
Brazil
Facility Name
Hospital Nossa Senhora da Conceicao
City
Porto Alegre
State/Province
RS
ZIP/Postal Code
91350-200
Country
Brazil
Facility Name
Sociedade Beneficente de Senhoras Hospital Sirio Libanes
City
Sao Paulo
State/Province
SP
ZIP/Postal Code
01308-050
Country
Brazil
Facility Name
Centro de Oncologia do Instituto de Radiologia
City
São Paulo
State/Province
SP
ZIP/Postal Code
01246-000
Country
Brazil
Facility Name
BC Cancer Agency - Vancouver Centre
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z 4E6
Country
Canada
Facility Name
QEII Health Sciences Centre - Nova Scotia Cancer Centre
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 1V7
Country
Canada
Facility Name
QEII Health Sciences Centre - Victoria General Site
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2Y9
Country
Canada
Facility Name
QEII Health Sciences Centre - Halifax Infirmary Site
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 3A7
Country
Canada
Facility Name
London Regional Cancer Program
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 4L6
Country
Canada
Facility Name
Princess Margaret Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 2M9
Country
Canada
Facility Name
CHUM, Hopital Saint-Luc
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H2X 3J4
Country
Canada
Facility Name
Royal Victoria Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3A 1A1
Country
Canada
Facility Name
Fundacion Centro de Investigacion Clinica CIC
City
Medellin
State/Province
Anquioquia
Country
Colombia
Facility Name
Hospital Universitario San Vicente de Paul
City
Medellin
State/Province
Antioquia
ZIP/Postal Code
0
Country
Colombia
Facility Name
Clinica Astorga
City
Medellin
State/Province
Antioquia
Country
Colombia
Facility Name
Centre Antoine Lacassagne
City
Nice
State/Province
Cedex 02
ZIP/Postal Code
06189
Country
France
Facility Name
Hopital Beaujon
City
Clichy Cedex
State/Province
Cedex
ZIP/Postal Code
92118
Country
France
Facility Name
Groupe Hospitalier Cochin, Cancer Quest AP-HP
City
Paris
State/Province
Cedex
ZIP/Postal Code
75679
Country
France
Facility Name
CHU-Hôpital Jean Minjoz
City
Besancon
ZIP/Postal Code
25030
Country
France
Facility Name
Hopital Saint-Andre
City
Bordeaux Cedex
ZIP/Postal Code
33075
Country
France
Facility Name
Centre Jean Perrin
City
Clermont Ferrand
ZIP/Postal Code
63011
Country
France
Facility Name
Polyclinique du Bois
City
Lille
ZIP/Postal Code
59000
Country
France
Facility Name
Centre Oscar Lambret
City
Lille
ZIP/Postal Code
59020
Country
France
Facility Name
Hopital Edouard Herriot
City
Lyon Cedex 03
ZIP/Postal Code
69437
Country
France
Facility Name
Centre Leon Berard
City
Lyon
ZIP/Postal Code
69008
Country
France
Facility Name
Chu La Timone
City
Marseille Cedex 5
ZIP/Postal Code
13385
Country
France
Facility Name
Clinique Hartmann
City
Neuilly Sur Seine
ZIP/Postal Code
92200
Country
France
Facility Name
Hopital Saint-Antoine
City
Paris
ZIP/Postal Code
75012
Country
France
Facility Name
Centre Eugene Marquis
City
Rennes Cedex
ZIP/Postal Code
35042
Country
France
Facility Name
Klinik fuer Innere Medizin, Gastroenterologie, Onkologie, Endokrinologie
City
Bad Berka
ZIP/Postal Code
99437
Country
Germany
Facility Name
Universitaetsklinikum Charité, Campus Virchow Klinikum
City
Berlin
ZIP/Postal Code
13353
Country
Germany
Facility Name
eps - early phase GmbH
City
Jena
ZIP/Postal Code
07743
Country
Germany
Facility Name
Frauenaerzte Pruener Gang
City
Kiel
ZIP/Postal Code
24103
Country
Germany
Facility Name
Klinik fuer Frauenheilkunde und Geburtshilfe, Universitaetsklinikum Schleswig-Holstein
City
Luebeck
ZIP/Postal Code
23538
Country
Germany
Facility Name
Universitaetsklinikum Schleswig-Holstein, Campus Luebeck
City
Luebeck
ZIP/Postal Code
23538
Country
Germany
Facility Name
Universitaetsklinikum Giessen und Marburg, Standort Marburg
City
Marburg
ZIP/Postal Code
35043
Country
Germany
Facility Name
Rhoen Klinikum Meiningen, Gynaekologie und Geburtshilfe
City
Meiningen
ZIP/Postal Code
98617
Country
Germany
Facility Name
Frauenklinik und Poliklinik, Klinikum rechts der Isar, Technische Universitaet Muenchen
City
Muenchen
ZIP/Postal Code
81675
Country
Germany
Facility Name
Department of Clinical Oncology, Tuen Mun Hospital
City
Tuen Mun
State/Province
New Territories
ZIP/Postal Code
0
Country
Hong Kong
Facility Name
Queen Mary Hospital
City
Hong Kong
ZIP/Postal Code
150001
Country
Hong Kong
Facility Name
Division of Haematology/Oncology, Department of Medicine, Queen Mary Hospital,
City
Hong Kong
Country
Hong Kong
Facility Name
Queen Elizabeth Hospital, Department of Clinical Oncology
City
Kowloon
Country
Hong Kong
Facility Name
Tuen Mun Hospital, Department of Clinical Oncology
City
Tuen Mun, New Territories
Country
Hong Kong
Facility Name
UNIMED Medical Institute
City
Wan Chai,
Country
Hong Kong
Facility Name
National Cancer Center
City
Goyang-si
State/Province
Gyeonggi-do
ZIP/Postal Code
410-769
Country
Korea, Republic of
Facility Name
Seoul National University Bundang Hospital
City
Seongnam-si
State/Province
Gyeonggi-do
ZIP/Postal Code
463-707
Country
Korea, Republic of
Facility Name
Seoul National University Hospital / Department of Internal Medecine
City
Seoul
State/Province
Republic Of Korea
ZIP/Postal Code
110-744
Country
Korea, Republic of
Facility Name
Asan Medical Center, Division of Oncology, Department of Internal Medicine
City
Seoul
State/Province
Republic Of Korea
ZIP/Postal Code
138-736
Country
Korea, Republic of
Facility Name
Yeungnam University Medical Center/Department of Internal medicine
City
Daegu
ZIP/Postal Code
705-717
Country
Korea, Republic of
Facility Name
Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine
City
Seoul
ZIP/Postal Code
120-752
Country
Korea, Republic of
Facility Name
Hospital Universitario Dr. Jose Eleuterio Gonzalez Centro Universitario contra el cancer
City
Monterrey
State/Province
Nuevo Leon
ZIP/Postal Code
64460
Country
Mexico
Facility Name
Hospital Christus Muguerza del Parque
City
Chihuahua
ZIP/Postal Code
31000
Country
Mexico
Facility Name
Cancer Care Clinic
City
Quezon City, Metro Manila
ZIP/Postal Code
1100
Country
Philippines
Facility Name
National University Hospital/Department of Heamatology-Oncology
City
Singapore
ZIP/Postal Code
119074
Country
Singapore
Facility Name
National Cancer Center/Department of Medical Oncology
City
Singapore
ZIP/Postal Code
169610
Country
Singapore
Facility Name
Corporacio Sanitaria Parc Tauli
City
Sabadell
State/Province
Barcelona
ZIP/Postal Code
08208
Country
Spain
Facility Name
Fundacion Hospital Alcorcon
City
Alcorcon
State/Province
Madrid
ZIP/Postal Code
28922
Country
Spain
Facility Name
Servicio de Oncologia
City
Barcelona
ZIP/Postal Code
08035
Country
Spain
Facility Name
Complexo Hospitalario Universitario A Coruña
City
La Coruña
ZIP/Postal Code
15006
Country
Spain
Facility Name
Centro Oncologico Md Anderson International España
City
Madrid
ZIP/Postal Code
28033
Country
Spain
Facility Name
Hospital Clinico San Carlos
City
Madrid
ZIP/Postal Code
28040
Country
Spain
Facility Name
Hospital 12 de Octubre
City
Madrid
ZIP/Postal Code
28041
Country
Spain
Facility Name
Hospital Universitario La Paz
City
Madrid
ZIP/Postal Code
28046
Country
Spain
Facility Name
Chang Gung Medical Foundation, Linkou Branch
City
Kuei-Shan
State/Province
Taoyuan
ZIP/Postal Code
333
Country
Taiwan
Facility Name
Changhua Christian Hospital
City
Changhua
ZIP/Postal Code
500
Country
Taiwan
Facility Name
Chung-Ho Memorial Hospital, Kaohsiung Medical University/Department of Surgery
City
Kaohsiung
ZIP/Postal Code
807
Country
Taiwan
Facility Name
Chi Mei Medical Center, Liouying
City
Liouying Township, Tainan,
ZIP/Postal Code
736
Country
Taiwan
Facility Name
Taichung Veterans General Hospital, Department of Surgery
City
Taichung
ZIP/Postal Code
407
Country
Taiwan
Facility Name
National Taiwan University Hospital/Department of Oncology
City
Taipei
ZIP/Postal Code
100
Country
Taiwan
Facility Name
Koo Foundation Sun Yat-Sen Cancer Center, Div. of Hematology/Oncology
City
Taipei
ZIP/Postal Code
112
Country
Taiwan
Facility Name
Taipei Veterans General Hospital
City
Taipei
ZIP/Postal Code
112
Country
Taiwan
Facility Name
Chi-Mei Medical Center
City
YungKang City, Tainan
ZIP/Postal Code
710
Country
Taiwan
Facility Name
Division of Surgery and Oncology
City
Liverpool
State/Province
Merseyside
ZIP/Postal Code
L69 3GA
Country
United Kingdom
Facility Name
Deparment of Cardiology
City
Glasgow
ZIP/Postal Code
G116NT
Country
United Kingdom
Facility Name
The Beatson West of Scotland Cancer Centre
City
Glasgow
ZIP/Postal Code
G12 0YH
Country
United Kingdom
Facility Name
Dainton Building
City
Leeds
ZIP/Postal Code
LS16 6QB
Country
United Kingdom
Facility Name
St James' Institute of Oncology
City
Leeds
ZIP/Postal Code
LS9 7TF
Country
United Kingdom
Facility Name
Management Offices, 4th Floor, Thomas Guy House
City
London
ZIP/Postal Code
SE1 9RT
Country
United Kingdom
Facility Name
Royal Marsden Hospital
City
London
ZIP/Postal Code
SW3 6JJ
Country
United Kingdom
Facility Name
Department of Medical Oncology
City
Manchester
ZIP/Postal Code
M20 4BX
Country
United Kingdom
Facility Name
Cardiology Department, Wythenshawe Hospital
City
Manchester
ZIP/Postal Code
M23 9LT
Country
United Kingdom
Facility Name
Nottingham City Hospital
City
Nottingham
ZIP/Postal Code
NG5 1PB
Country
United Kingdom

12. IPD Sharing Statement

Links:
URL
https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6181114&StudyName=A%20Continuation%20Study%20Using%20Sunitinib%20Malate%20For%20Patients%20Leaving%20Treatment%20On%20A%20Previous%20Sunitinib%20Study.
Description
To obtain contact information for a study center near you, click here.

Learn more about this trial

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

We'll reach out to this number within 24 hrs